ALS drug trial halted early: what we know
Disease control
Terminated
This study tested a new drug called VRG50635 in 54 people with ALS to see if it was safe and tolerable. The trial was stopped early, and its main goal was to track side effects and how the drug moves through the body. It did not aim to cure ALS, but to gather safety information f…
Phase: PHASE1 • Sponsor: Verge Genomics • Aim: Disease control
Last updated May 15, 2026 11:55 UTC